Astronics Corporation, through its subsidiaries, designs and manufactures products for the aerospace, defense, and electronics industries in the United States, rest of North America, Asia, Europe, South America, and internationally. It operates in two segments, Aerospace and Test Systems. The Aerospace segment offers lighting and safety systems, electrical power generation systems, distribution and seat motions systems, aircraft structures, avionics products, systems certification, and other products. This segment serves airframe manufacturers (OEM) that build aircraft for the commercial transport, military, and general aviation markets; suppliers to OEMs; and aircraft operators, such as airlines; suppliers to the aircraft operators; and branches of the U.S. Department of Defense. The Test Systems segment designs, develops, manufactures, and maintains automated test systems that support the aerospace and defense, communications, and mass transit industries, as well as training and simulation devices for commercial and military applications. This segment serves OEMs and prime government contractors for electronics and military products. The company was incorporated in 1968 and is headquartered in East Aurora, New York.…
Astronics (ATRO) Signs BETA Deal, Is The Stock Still Cheap?
Astronics (NASDAQ: ATRO) is listed on Nasdaq, where its shares trade in USD. It belongs to the Aerospace & Defense industry, part of the Industrials sector, and reports about 2,700 employees.
The shares were at 55.12 USD on 20 November 2026, up 47.0% over 52 weeks. Its 52-week range is 36.51 USD to 94.46 USD: the price is 41.6% below the high and 51.0% above the low.
At a market capitalisation of 2.38B USD, it trades at 18.1 times trailing earnings and 17.0 times forward earnings. The median trailing P/E of its 20 largest Aerospace & Defense peers is 30.8, a discount of 41% for ATRO.
Astronics reports return on equity of 21.0%, an operating margin of 16.1% and revenue up 28.5% year over year.
Its debt exceeds its cash by 318.23M USD, a debt-to-equity ratio of 2.70. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 4 analysts cover the stock, with an average rating of Buy; their mean price target of 91.75 USD is 66.5% above the current price. The next earnings report is expected on 4 March 2027.